[go: up one dir, main page]

MX2018008663A - Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal. - Google Patents

Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.

Info

Publication number
MX2018008663A
MX2018008663A MX2018008663A MX2018008663A MX2018008663A MX 2018008663 A MX2018008663 A MX 2018008663A MX 2018008663 A MX2018008663 A MX 2018008663A MX 2018008663 A MX2018008663 A MX 2018008663A MX 2018008663 A MX2018008663 A MX 2018008663A
Authority
MX
Mexico
Prior art keywords
mesenteroides
fetal
subsp
leuconostoc
metabolic programming
Prior art date
Application number
MX2018008663A
Other languages
English (en)
Inventor
ZAMBRANO GONZÁLEZ Elena
Catalina Castro Rodríguez Diana
Original Assignee
Instituto Nac De Ciencias Medicas Y Nutricion Salvador Zubiran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Nac De Ciencias Medicas Y Nutricion Salvador Zubiran filed Critical Instituto Nac De Ciencias Medicas Y Nutricion Salvador Zubiran
Priority to MX2018008663A priority Critical patent/MX2018008663A/es
Publication of MX2018008663A publication Critical patent/MX2018008663A/es
Priority to US17/258,195 priority patent/US20210268039A1/en
Priority to GB2100170.6A priority patent/GB2590202B/en
Priority to ES202090069A priority patent/ES2820874B2/es
Priority to PCT/IB2019/055932 priority patent/WO2020012412A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención busca implementar un nuevo uso de los probióticos, en especial de la cepa Leuconostoc mesenteroides subsp. mesenteroides SD23 para ser consumida durante la gestación y lactancia en la madre obesa y prevenir parcial o totalmente las alteraciones metabólicas ocasionadas por una dieta alta en grasa, tanto en la madre como en las crías.
MX2018008663A 2018-07-13 2018-07-13 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal. MX2018008663A (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MX2018008663A MX2018008663A (es) 2018-07-13 2018-07-13 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.
US17/258,195 US20210268039A1 (en) 2018-07-13 2019-07-11 Use of leuconostoc mesenteroides subsp. mesenteroides sd23 for maternal fetal metabolic programming
GB2100170.6A GB2590202B (en) 2018-07-13 2019-07-11 Use of leuconostoc mesenteroides subsp. mesenteroides sd23 for maternal fetal metabolic programming
ES202090069A ES2820874B2 (es) 2018-07-13 2019-07-11 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal
PCT/IB2019/055932 WO2020012412A2 (es) 2018-07-13 2019-07-11 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programación metabólica materno fetal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018008663A MX2018008663A (es) 2018-07-13 2018-07-13 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.

Publications (1)

Publication Number Publication Date
MX2018008663A true MX2018008663A (es) 2018-11-09

Family

ID=65023009

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008663A MX2018008663A (es) 2018-07-13 2018-07-13 Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.

Country Status (5)

Country Link
US (1) US20210268039A1 (es)
ES (1) ES2820874B2 (es)
GB (1) GB2590202B (es)
MX (1) MX2018008663A (es)
WO (1) WO2020012412A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467695C (en) * 2003-05-20 2010-03-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from leuconostoc as neutraceuticals
ES2770401T3 (es) * 2012-09-20 2020-07-01 Prothera Inc Composiciones probióticas para el tratamiento de la obesidad y afecciones relacionadas con la obesidad

Also Published As

Publication number Publication date
WO2020012412A3 (es) 2020-03-19
WO2020012412A2 (es) 2020-01-16
ES2820874R2 (es) 2021-09-22
GB202100170D0 (en) 2021-02-24
ES2820874A2 (es) 2021-04-22
ES2820874B2 (es) 2023-09-06
GB2590202B (en) 2022-05-25
GB2590202A (en) 2021-06-23
US20210268039A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
MX374421B (es) Mioinositol y uno o más probióticos y sus usos.
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
WO2015048346A3 (en) Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control
MX2021008858A (es) Vitamina b2 para la diabetes gestacional.
PH12016500774A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
PH12018501263A1 (en) Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
PH12018501297A1 (en) Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
PH12016501868B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
MX2018008663A (es) Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.
MX2016012338A (es) Composiciones nutricionales sinteticas especificas de genero y sistemas nutricionales que las comprenden.
PH12016501947B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
MX2019015889A (es) Administracion de vitamina b6 materna para la prevencion del aumento de la adiposidad, el sobrepeso a la obesidad en la descendencia.
MX2018011512A (es) Uso de insulina para promover el vaciamiento gástrico.
WO2017102391A3 (en) Nutritional supplement comprising microalgae, vitamins and minerals
PH12016501817A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016500915A1 (en) Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers
Iwamoto et al. Eating habits in a north coast village in Iwate-prefecture change and the background
PH22016000733U1 (en) FORMULATION OF SEA CUCUMBER (Holothuria scabra) POLVORON WITH CRUSHED PINEAPPLE
UA87070U (ru) Способ профилактики железодефицита у детей грудного возраста, получающих естественное вскармливание
TWD175974S (zh) 杯蓋
MY198454A (en) Nutritional Tablets and Methods of Making the Same
UA98217U (uk) Спосіб моделювання виразок шлунка